Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report. (Q44098314)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 January 2012

edit

Language	Label	Description	Also known as
English	Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report.	scientific article published on 17 January 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

title

Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

main subject

central nervous system lymphoma

1 reference

based on heuristic

inferred from title

primary central nervous system lymphoma

1 reference

based on heuristic

inferred from title

bendamustine

1 reference

based on heuristic

inferred from title

author

Stephen B Tatter

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Glenn J Lesser

series ordinal

9

object named as

Glenn J Lesser

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

author name string

Jaclyn J Renfrow

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Alisha Detroye

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Michael Chan

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Thomas Ellis

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Kevin McMullen

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Annette Johnson

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Ryan Mott

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

publication date

17 January 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

published in

Journal of Neuro-Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

volume

107

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

page(s)

659-663

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

cites work

Decreasing incidence rates of primary central nervous system lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Chemotherapy for primary central nervous system lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Combined modality therapy for primary CNS lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

RNA-mediated neurodegeneration in repeat expansion disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Treatment of primary central nervous system lymphoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Salvage therapy with single agent bendamustine for recurrent glioblastoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Primary central nervous system lymphoma: a single-centre experience of 55 unselected cases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-011-0788-X

retrieved

21 January 2018

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22249693

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary central nervous system lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22249693

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22249693

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22249693

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic management of refractory or relapsed primary central nervous system lymphomas.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22249693

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22249693

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11060-011-0788-X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

PubMed publication ID

22249693

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22249693

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249693%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44098314&oldid=2229834124"